SCHEMBL22739288

SCHEMBL22739288

C=C/C(=C\N=C/C)c1ccnc(C(=O)NC2=CC(c3nncn3C[C@H](C)O)=CCC2)c1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 17/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23720763 0.67 MAP3K5 (0.37) CBLB
SCHEMBL23721141 0.59 MAP3K5 (0.45) CBLB
SCHEMBL22738993 0.57 MAP3K5 (0.42) CBLB
SCHEMBL23721207 0.56 MAP3K5 (0.45) —
SCHEMBL23721183 0.56 CBLB (0.41) CBLB
SCHEMBL8842567 0.52 CBLB (0.52) CBLB
SCHEMBL25492039 0.49 CA12 (0.38) —
SCHEMBL16363837 0.49 AKT1 (0.41) —
SCHEMBL24977131 0.47 CES2 (0.33) —
SCHEMBL30236724 0.47 KDM4E (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3363797-B1 ORAL DOSAGE FORM OF APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS GILEAD SCIENCES INC (US) 2020-12-02 — — EP disclosed
Send feedback